Covid19 Clinical Trial - Use of the Nasal Cannula During COVID-19

Status Enrolling by invitation

Clinical Trial Summary

The objective of this investigation is to determine the incidence of the use of the low flow nasal cannula in suspected or confirmed cases with Covid-19

Clinical Trial Description

An anonymous questionnaire will be sent to a group of anesthesiologists via email which will allow to collect information about the use, or not, of the low flow nasal cannula, the type of procedure where it is used, and the type of personal protection weared. ;

Study Design

Related Conditions & MeSH terms

COVID 19

Clinical Trial Details

NCT number	NCT04376580
Study type	Observational
Source	Tiva Group
Contact
Status	Enrolling by invitation
Phase
Start date	April 30, 2020
Completion date	November 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04333732` - CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION	Phase 3
Completed	`NCT04357457` - Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia	Phase 3
Terminated	`NCT04435795` - Inhaled Ciclesonide for Outpatients With COVID19	Phase 2/Phase 3
Completed	`NCT04357444` - Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19	Phase 2
Completed	`NCT04357834` - WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Not yet recruiting	`NCT05052320` - Audiological Assessment of Recovered Covid 19 Subjects.
Withdrawn	`NCT04426344` - Core Warming of COVID-19 Patients	N/A
Recruiting	`NCT05595031` - Evaluation of the Clinical Impact of Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)
Terminated	`NCT04371978` - Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19	Phase 3
Terminated	`NCT04401410` - Anti-SARS Cov-2 T Cell Infusions for COVID 19	Phase 1
Completed	`NCT04445337` - Stellate Ganglion Blockade in COVID-19 Positive Patients	N/A
Active, not recruiting	`NCT04374487` - Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications	Phase 2
Completed	`NCT04403243` - COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19	Phase 2
Completed	`NCT04375644` - Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT)
Completed	`NCT04394078` - Impact of COVID-19 Pandemic on Depression and Quality of Life
Recruiting	`NCT04407923` - Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment
Completed	`NCT04426305` - Community Health Workers Against COVID19	N/A
Withdrawn	`NCT04519411` - Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure	N/A
Recruiting	`NCT04492514` - Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation	Phase 2
Completed	`NCT04399980` - Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation	Phase 2